Diabetes

Scientists look to genetics to explain why GLP-1 drugs work for some people but not for others

What happens when your body suddenly stops making the one hormone that keeps your blood sugar in check?

Diabetic eye disease robs sight from millions. But there are often ways to save vision

Advocates are lightening mental health burdens, improving pregnancy care and helping patients in developing countries

This autoimmune disease impacts millions of people worldwide, with some underserved communities bearing the brunt

A new drug slows insulin-dependent diabetic deterioration and has sped up development of a complete remedy

Living with type 1 diabetes today is leaps and bounds easier than it was decades ago. Things are only getting better

How a father’s love, entrepreneurship and tech advances could lead to a working artificial pancreas

Genetic screening can mean that people at risk of type 1 diabetes get earlier treatment and better outcomes

Whether intermittent fasting helps anyone is unclear, but it does have known health risks. Who can try the dieting trend, and who should avoid it?

Scientists treated a person’s type 1 diabetes with genetically modified insulin-producing cells that evaded immune system attacks. This is the first therapy for the condition that does not require immunosuppressant drugs

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes